Overview

To Determine the Food Effect and Bioavailability of Three Formulations of Veliparib in Subjects With Solid Tumors

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
Compare the bioavailability of three veliparib formulations in subjects with solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Abbott
AbbVie
Treatments:
Veliparib